| Serum Hsp70 as an early predictor of fatal outcome after severe traumatic brain injury in males AB Da Rocha, C Zanoni, GR De Freitas, C André, S Himelfarb, ... Journal of neurotrauma 22 (9), 966-977, 2005 | 88 | 2005 |
| Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats ECS Ferreira, RH Bortolin, FP Freire-Neto, KSC Souza, JF Bezerra, ... Nutrition Research 40, 48-56, 2017 | 27 | 2017 |
| Tumor necrosis factor-α and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone ST Himelfarb, FA Silva, SS Arazi, CM Farjado, A Garofalo, MC Bertolami, ... Walter de Gruyter 26 (1), 37-40, 2011 | 14 | 2011 |
| Analysis of the mRNA expression of the S100β protein in adipocytes of patients with diabetes mellitus, type 2 MY Hamasaki, MH Hirata, RDC Hirata, ST Himelfarb, LMG Campos, ... Arquivos Brasileiros de Endocrinologia & Metabologia 56, 435-440, 2012 | 1 | 2012 |
| Association of the atherosclerosis with tLR2, TLR4 and IL-6 polymorphisms in type 2 diabetics patients FA Silva, MH Salem, MP Sampaio, ST Himelfarb, MC Bertolami, ... Atherosclerosis Supplements 10 (3), 14-15 res. D 008, 2009 | 1 | 2009 |
| Efeito da pioglitazona sobre o remodelamento ósseo em diabetes tipo 2 ST Himelfarb Universidade de São Paulo, 2013 | | 2013 |
| Influence of high glucose concentration on bone metabolism parameters in C57BL/6 mice fed with a high-fat diet RH Bortolin, ST Himelfarb, FM Santos, AML Oliveira, FP Freire-Neto, ... Diabetes 61, A709 res. 2866-PO, 2012 | | 2012 |
| Influence of high glucose concentration on bone metabolism in mice C57BL/6 induced with high-fat diet RH Bortolin, FM Santos, AM Oliveira, FP Freire-Neto, JF Bezerra, ... Resumos, 2011 | | 2011 |
| Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals ST Himelfarb, FA Silva, SS Arazi, CM Farjado, R Oliveira, MC Bertolami, ... Clinical Chemistry and Laboratory Medicine 48 (8), A67 res. B12, 2010 | | 2010 |
| Association of TLR2, TLR4, TNF-'alpha'and IL-6 gene polymorphisms and expression with atherosclerosis in type 2 diabetes patients MH Hirata, FA Silva, ST Himelfarb, MF Sampaio, LG Lima Neto, M Saleh, ... Clinical Chemistry 56 (6 suppl.), A88-A89 res. B, 2010 | | 2010 |
| Thiazolidinediones and its negative effects on bone metabolism in Brazilian individuals with type 2 diabetes mellitus MH Hirata, ST Himelfarb, MF Marques, FA Silva, AC Rodrigues, ... CLINICAL CHEMISTRY 55 (6), A223-A223, 2009 | | 2009 |
| Expression of ppargamma, ppargamma2, SUR1 and KIR6. 2 MRNA peripheral blood leukocytes and adipose tissue in Type 2 Diabetes mellitus patients trated with pioglitazone MFSF Marques, ST Himelfarb, AC Rodrigues, FA Silva, VF Silva, ... Resumos, 2009 | | 2009 |
| Thiazolidinediones and its negative effects on bone metabolism in Brasilian individuals with type 2 diabetes mellitus MH Hirata, ST Himelfarb, MFSF Marques, FA Silva, AC Rodrigues, ... Clinical Chemistry 55 (6), su-41, 2009 | | 2009 |
| Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6. 2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone MH Hirata, MFSF Marques, ST Himelfarb, FA Silva, MI Monaco, ... Clinical Chemistry 55 (6 suppl.), A222-A223 res. E, 2009 | | 2009 |
| Avaliação da atividade osteoblástica e osteoclástica em diabéticos tipo 2 em tratamento com pioglitazonas ST Himelfarb Universidade de São Paulo, 2008 | | 2008 |
| Effects of pioglitazone on RANK and RANKL mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus MH Hirata, ST Himelfarb, MFSF Marques, MI Monaco, AC Rodrigues, ... Clinical Chemistry 54 (6), A165 res. D-67, 2008 | | 2008 |
| Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6. 2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus MH Hirata, MFSF Marques, ST Himelfarb, AC Rodrigues, FA Silva, ... Clinical Chemistry 54 (6), A165 res. D-69, 2008 | | 2008 |
| Estudo da expressão gênica do RANK e RANKL em indivíduos diabéticos tipo 2 em tratamento com pioglitazona ST Himelfarb, MFSF Marques, VF Silva, MI Monaco, MF Sampaio, ... Revista Brasileira de Ciências Farmacêuticas 43, 62 res. 119, 2007 | | 2007 |
| Estudo de expressão gênica do PPARgamma2, SUR1 e KIR6. 2 em indivíduos diabéticos melito tipo 2 (DMT2) tratados com pioglitazona MFSF Marques, ST Himelfarb, VF Silva, MI Monaco, MF Sampaio, ... Revista Brasileira de Ciências Farmacêuticas 43, 65 res. 125, 2007 | | 2007 |
